Clinical Trials Directory

Trials / Completed

CompletedNCT04010370

Correlation of Several Formulas to Evaluate Insulin Sensitivity With the Predicted M Index

Correlation of Several Formulas to Evaluate Insulin Sensitivity With the Predicted M Index (PREDIM) in Healthy Individuals

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
University of Guadalajara · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

Recently, an index based on the oral insulin sensitivity index with glucose (OGIS) has been proposed in combination with anthropometric variables, called PREDIcted M (PREDIM), however, there is no evidence of the correlation of this with respect to the various indices (McAuley, Belfiore, Cederholm, Avignon, Matsuda, Gutt, Stumvoll, HOMA-IR (Homeostatic Model Assessment for Insulin Resistance), ISI (Insulin Sensitivity Index), Raynaud, QUICKI (The quantitative insulin sensitivity check index), FIRI (Fasting Insulin Resistance Index), Bennett, TyG (triglycerides and glucose index)) in healthy patients.

Detailed description

Analytical cross-sectional study with 25 healthy patients of both genders (male and female) from 30 to 60 years old, residents of the metropolitan area of Guadalajara. They will be operated on for a 3-hour oral glucose tolerance test. The insulin sensitivity will be calculated with the PREDIM, Matsuda, McAuley, Belfiore, Cederholm, Avignon, Gutt, Stumvoll, HOMA-IR, ISI, Raynaud, QUICKI, FIRI, Bennett and TyG indexes. This protocol is already approved by the local ethics committee and written informed consent it's going to be obtained from all volunteers. The statistical analysis will be presented with measures of central tendency and dispersion, mean and standard deviation. The nominal variables in numbers and percentages. The Kolmogorov-Smirnov test will be performed to determine if the variables follow a normal distribution. To correlate the formulas used to evaluate the insulin sensitivity with the PREDIcted M (PREDIM) technique, the Pearson or Spearman correlation will be used according to the distribution.

Conditions

Timeline

Start date
2019-02-01
Primary completion
2020-02-28
Completion
2020-02-28
First posted
2019-07-08
Last updated
2020-12-03
Results posted
2020-12-03

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04010370. Inclusion in this directory is not an endorsement.